- Home
- ALDX vs BGH Comparison
ALDX vs BGH Comparison
Compare ALDX & BGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- BGH
- Stock Information
- Founded
- ALDX 2004
- BGH 2012
- Country
- ALDX United States
- BGH United States
- Employees
- ALDX N/A
- BGH N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- BGH Investment Managers
- Sector
- ALDX Health Care
- BGH Finance
- Exchange
- ALDX Nasdaq
- BGH Nasdaq
- Market Cap
- ALDX 304.9M
- BGH 318.8M
- IPO Year
- ALDX 2014
- BGH N/A
- Fundamental
- Price
- ALDX $6.91
- BGH $15.21
- Analyst Decision
- ALDX Strong Buy
- BGH
- Analyst Count
- ALDX 2
- BGH 0
- Target Price
- ALDX $10.00
- BGH N/A
- AVG Volume (30 Days)
- ALDX 636.8K
- BGH 61.5K
- Earning Date
- ALDX 05-01-2025
- BGH 01-01-0001
- Dividend Yield
- ALDX N/A
- BGH 10.06%
- EPS Growth
- ALDX N/A
- BGH N/A
- EPS
- ALDX N/A
- BGH N/A
- Revenue
- ALDX N/A
- BGH N/A
- Revenue This Year
- ALDX N/A
- BGH N/A
- Revenue Next Year
- ALDX N/A
- BGH N/A
- P/E Ratio
- ALDX N/A
- BGH N/A
- Revenue Growth
- ALDX N/A
- BGH N/A
- 52 Week Low
- ALDX $2.71
- BGH $11.92
- 52 Week High
- ALDX $7.20
- BGH $14.50
- Technical
- Relative Strength Index (RSI)
- ALDX 61.80
- BGH 27.55
- Support Level
- ALDX $6.79
- BGH $15.13
- Resistance Level
- ALDX $7.20
- BGH $15.37
- Average True Range (ATR)
- ALDX 0.56
- BGH 0.18
- MACD
- ALDX 0.03
- BGH -0.07
- Stochastic Oscillator
- ALDX 88.02
- BGH 8.75
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.
About BGH Barings Global Short Duration High Yield Fund of Beneficial Interests
Barings Global Short Duration High Yield Fund is a diversified, closed-end management investment company. Its investment objective is to seek as high a level of current income as the Adviser determines is consistent with capital preservation.